Related Experiment Video
Updated: Jan 6, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
The therapeutic effects of various tonic traditional Chinese medicines on demyelinating diseases
Cunming Lv1,2,3, Qiang Li1,2,3, Jinhao Chen4,5,6
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, Hubei, China.
Abstract:
Demyelinating diseases, a prevalent group of neurological disorders, lead to impaired nerve conduction and sensorimotor dysfunctions. Despite existing treatments demonstrating some efficacy, their limitations have driven research toward exploring natural remedies. This review summarizes the therapeutic potential of four traditional tonic Chinese herbal medicines-ginsenosides, deer antler polypeptides, resveratrol, and ginkgo leaf extracts-for demyelinating diseases. The selection of these four components is based on their reported neuroprotective and immunomodulatory effects in recent studies. Ginsenosides can modulate immune functions, counteract oxidative stress, and promote remyelination in demyelinating injuries caused by inflammatory conditions. Deer antler polypeptides facilitate remyelination by regulating the expression of myelin-related proteins. Resveratrol exhibits antioxidant and anti-inflammatory properties, alleviating the symptoms of chronic demyelinating diseases induced by metabolic disturbances. Among the components of ginkgo leaf extracts, flavonoids protect neurons and inhibit apoptosis, while terpene lactones modulate the expression of myelin-related genes. This review summarizes the current research on these tonic Chinese herbal medicines and discusses their potential applications in treating demyelinating diseases. This comprehensive review evaluates the research progress on these essential tonic Chinese herbal medicines, revealing their potential applications in demyelinating disease treatments. It may offer a basis for future investigations and potential implications for clinical research.
More Related Videos
04:28Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment
Published on: June 27, 2025
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...